1 罗洁君, 管 宇, 范 丽, 等. 慢性阻塞性肺疾病临床及影像学表型研究进展[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(6): 900-903.
2 张 明. 中老年人群慢性阻塞性肺疾病流行状况及影响因素[J]. 中国卫生工程学, 2023, 22(1): 63-65+72.
3 Pavic T, Dilber D, Kifer D, et al. N-glycosylation patterns of plasma proteins and immunoglobulin G in chronic obstructive pulmonary disease[J]. J Transl Med, 2018, 16(1): 323.
4 Yu J, Song Y, Tian W. How to select IgG subclasses in developing anti-tumor therapeutic antibodies[J]. J Hematol Oncol, 2020, 13(1): 45.
5 Jing Z, Deng H, Ma J, et al. Expression of immunoglobulin G in human podocytes, and its role in cell viability and adhesion[J]. Int J Mol Med, 2018, 41(6): 3296-3306.
6 Ferri S, Crimi C, Campisi R, et al. Impact of asthma on bronchiectasis severity and risk of exacerbations[J]. J Asthma, 2022, 59(3): 469-475.
7 Fawzy A, Putcha N. Hypogammaglobulinemia in COPD: Treatable Phenotype or Surrogate Marker?[J]. Chest, 2020, 158(4): 1296-1297.
8 沈佩雷, 孙攀博, 罗 彬. 慢性阻塞性肺病血清IgG亚型水平与急性加重及住院风险的关系[J]. 中国当代医药, 2021, 28(14): 43-46.
9 中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 慢性阻塞性肺疾病基层诊疗指南(2018年)[J]. 中华全科医师杂志, 2018, 17(11): 856-870.
10 李 倩, 李永哲. 成人血清IgG亚类参考值的建立[J]. 上海医学检验杂志, 2001, 16(3): 181-182.
11 Gayle AV, Minelli C, Quint JK. Respiratory-related death in individuals with incident asthma and COPD: a competing risk analysis[J]. BMC Pulm Med, 2022, 22(1): 28.
12 朱卫锋. 中国慢性阻塞性肺疾病管理现状与思考[J]. 上海医药, 2023, 44(2): 45-48.
13 Boixeda R, Capdevila JA, Vicente V, et al. Gamma globulin fraction of the proteinogram and chronic obstructive pulmonary disease exacerbations[J]. Med Clin(Barc), 2017, 149(3): 107-113.
14 卢斯霞. 丙种球蛋白作为感染所致的慢性阻塞性肺疾病急性恶化期 预后标志物的可行性[J]. 临床与病理杂志, 2018, 38(9): 1864-1870.
15 Barton J, Barton C, Bertoli L. Duration of frequent or severe respiratory tract infection in adults before diagnosis of IgG subclass deficiency[J]. PLoS One, 2019, 14(5): e0216940.
16 Wong M, Han YY, Rosser F, et al. Persistent overweight or obesity, lung function, and asthma exacerbations in Puerto Rican youth[J]. Ann Allergy Asthma Immunol, 2022, 128(4): 408-413.e2.
17 Kang J, Park S, Chae EJ, et al. Long-term clinical course and outcomes of immunoglobulin G4-related lung disease[J]. Respir Res, 2020, 21(1): 273.
18 孙 印, 何士杰, 景卫革, 等. 慢性阻塞性肺疾病免疫发病机制研究进展[J]. 医学综述, 2019, 25(13): 2574-2578.
19 Stockley RA, Halpin D, Celli BR, et al. Chronic obstructive pulmonary disease biomarkers and their interpretation[J]. Am J Respir Crit Care Med, 2019, 199(10): 1195-1204.
20 Ba Ta T, Tran Viet T, Xuan Nguyen K, et al. Changes in serum immunoglobulin G subclasses during the treatment of patients with chronic obstructive pulmonary disease with infectious exacerbations[J]. Adv Respir Med, 2022, 90(6): 500-510.
21 Palikhe NS, Niven M, Fuhr D, et al. Low immunoglobulin levels affect the course of COPD in hospitalized patients[J]. Allergy Asthma Clin Immunol, 2023, 19(1): 10.
22 Hyun L, Cara K, Andre M, et al. The impact of IgG subclass deficiency on the risk of mortality in hospitalized patients with COPD[J]. Respir Res, 2022, 23(1): 141.
23 Leitao Filho FS, Mattman A, Schellenberg R, et al. Serum IgG levels and risk of COPD hospitalization: A pooled Meta-analysis[J]. Chest, 2020, 158(4): 1420-1430.
24 Leitao Filho FS, Ra SW, Mattman A, et al. Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD[J]. Respir Res, 2018, 19(1): 30.
25 Barton JC, Clayborn BJ, Bertoli LF, et al. Factors associated with IgG levels in adults with IgG subclass deficiency[J]. BMC Immunol, 2021, 22(1): 53.
26 马印图, 陈 莉, 张 怡, 等. 两种检测血型抗体IgG亚型的方法比较[J]. 河北医学, 2020, 26(5): 775-778.
27 丁 航, 刘 源, 张连峰, 等. IgG4相关性疾病的临床特征研究[J]. 中国全科医学, 2022, 25(5): 584-588.
28 Sergio LFF, Won RS, Andre M, et al. Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD[J]. Respir Res, 2018, 19(1): 30.
29 闫 雷, 靳德甫, 李 畅, 等. 血清IgG4水平对常见自身免疫性疾病的鉴别诊断价值[J]. 中国免疫学杂志, 2022, 38(5): 604-608, 613.
30 刘英贤, 谢燕丕, 李惠怡, 等. 过敏性哮喘患儿外周血T细胞免疫球蛋白及黏蛋白域4和血清免疫球蛋白G4的水平变化及意义[J]. 中国医药, 2020, 15(5): 685-689.